KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arbutus Biopharma (ABUS) Debt to Equity (2016 - 2017)

Arbutus Biopharma's Debt to Equity history spans 2 years, with the latest figure at $0.07 for Q4 2017.

  • For Q4 2017, Debt to Equity rose 11.25% year-over-year to $0.07; the TTM value through Dec 2017 reached $0.07, up 11.25%, while the annual FY2017 figure was $0.07, 11.25% up from the prior year.
  • Debt to Equity for Q4 2017 was $0.07 at Arbutus Biopharma, down from $0.07 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.07 in Q3 2017 and bottomed at $0.06 in Q4 2016.